Valsartan NDC 29300-234

NDC codes

FDA NDC Directory

Product NDC (as listed)29300-234Labeler and product segments. Claims need a package NDC.

Product NDC at billing width29300-0234Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
29300-234-10	29300023410	1000 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (29300-234-10)Marketed from May 15, 2018
29300-234-13	29300023413	30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (29300-234-13)Marketed from May 15, 2018
29300-234-19	29300023419	90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (29300-234-19)Marketed from May 15, 2018

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Valsartan
Generic name (nonproprietary): valsartan
Active ingredients: Valsartan — 160 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Unichem Pharmaceuticals (USA), Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 209261
Marketing start: May 4, 2018
Listing expires: Dec 31, 2026
Other FDA classes: Angiotensin 2 Receptor Antagonists (Mechanism)
Identifiers: Product ID 29300-234_4d1e743f-8954-4634-b95b-adb7ae41a549SPL ID 4d1e743f-8954-4634-b95b-adb7ae41a549SPL set ID 93b82a9f-dc0a-4f7d-b0d4-4adf0d917b7eRxCUI 349199, 349200, 349201, 349483UNII 80M03YXJ7IUPC 0329300233193, 0329300232196, 0329300234190, 0329300235197
Pharmacologic class: Angiotensin 2 Receptor Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N429300023410 followed by a unit qualifier and the quantity

Package 29300-0234-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Sep 9, 2021. This label includes a boxed warning.

Indications (excerpt from the label)

Valsartan tablets are an angiotensin II receptor blocker (ARB) indicated for: Hypertension , to lower blood pressure in adults and children 6 years and older. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions ( 1.1 ) Heart failure (NYHA class II-IV), to reduce hospitalization for heart failure in adults ( 1.2 ) Post-myocardial infarction , for the reduction of cardiovascular mortality in clinically stable patients with left ventricular failure or left ventricular dysfunction following myocardial infarction in adults ( 1.3 ) 1.1 Hypertension Valsartan tablets are indicated for the treatment of hypertension, to lo…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 209261

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 209261
Product	Strength	Form · route	Labeler	Product NDC
Valsartan	Valsartan 40 mg/1	Tablet, Film coatedOral	Unichem Pharmaceuticals (USA), Inc.	29300-232
Valsartan	Valsartan 320 mg/1	Tablet, Film coatedOral	Unichem Pharmaceuticals (USA), Inc.	29300-235
Valsartan	Valsartan 80 mg/1	Tablet, Film coatedOral	Unichem Pharmaceuticals (USA), Inc.	29300-233